BEAM
Price
$20.29
Change
+$1.11 (+5.79%)
Updated
Jul 8, 04:59 PM (EDT)
Capitalization
1.93B
34 days until earnings call
MRUS
Price
$52.38
Change
-$0.20 (-0.38%)
Updated
Jul 8, 04:59 PM (EDT)
Capitalization
3.9B
23 days until earnings call
Interact to see
Advertisement

BEAM vs MRUS

Header iconBEAM vs MRUS Comparison
Open Charts BEAM vs MRUSBanner chart's image
Beam Therapeutics
Price$20.29
Change+$1.11 (+5.79%)
Volume$60.48K
Capitalization1.93B
Merus
Price$52.38
Change-$0.20 (-0.38%)
Volume$10.21K
Capitalization3.9B
BEAM vs MRUS Comparison Chart in %
Loading...
BEAM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
MRUS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
BEAM vs. MRUS commentary
Jul 09, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BEAM is a StrongBuy and MRUS is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 09, 2025
Stock price -- (BEAM: $20.30 vs. MRUS: $52.33)
Brand notoriety: BEAM and MRUS are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: BEAM: 156% vs. MRUS: 35%
Market capitalization -- BEAM: $1.93B vs. MRUS: $3.9B
BEAM [@Biotechnology] is valued at $1.93B. MRUS’s [@Biotechnology] market capitalization is $3.9B. The market cap for tickers in the [@Biotechnology] industry ranges from $309.49B to $0. The average market capitalization across the [@Biotechnology] industry is $2.38B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BEAM’s FA Score shows that 1 FA rating(s) are green whileMRUS’s FA Score has 1 green FA rating(s).

  • BEAM’s FA Score: 1 green, 4 red.
  • MRUS’s FA Score: 1 green, 4 red.
According to our system of comparison, MRUS is a better buy in the long-term than BEAM.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BEAM’s TA Score shows that 6 TA indicator(s) are bullish while MRUS’s TA Score has 4 bullish TA indicator(s).

  • BEAM’s TA Score: 6 bullish, 4 bearish.
  • MRUS’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, BEAM is a better buy in the short-term than MRUS.

Price Growth

BEAM (@Biotechnology) experienced а +15.80% price change this week, while MRUS (@Biotechnology) price change was -0.63% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +9.39%. For the same industry, the average monthly price growth was +14.41%, and the average quarterly price growth was +12.94%.

Reported Earning Dates

BEAM is expected to report earnings on Nov 10, 2025.

MRUS is expected to report earnings on Oct 30, 2025.

Industries' Descriptions

@Biotechnology (+9.39% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
MRUS($3.9B) has a higher market cap than BEAM($1.93B). MRUS YTD gains are higher at: 25.042 vs. BEAM (-18.145). MRUS has higher annual earnings (EBITDA): -298.55M vs. BEAM (-399.03M). BEAM has more cash in the bank: 1.22B vs. MRUS (458M). MRUS has less debt than BEAM: MRUS (9.86M) vs BEAM (158M). BEAM has higher revenues than MRUS: BEAM (63.6M) vs MRUS (54.7M).
BEAMMRUSBEAM / MRUS
Capitalization1.93B3.9B49%
EBITDA-399.03M-298.55M134%
Gain YTD-18.14525.042-72%
P/E RatioN/AN/A-
Revenue63.6M54.7M116%
Total Cash1.22B458M266%
Total Debt158M9.86M1,603%
FUNDAMENTALS RATINGS
MRUS: Fundamental Ratings
MRUS
OUTLOOK RATING
1..100
54
VALUATION
overvalued / fair valued / undervalued
1..100
60
Fair valued
PROFIT vs RISK RATING
1..100
29
SMR RATING
1..100
97
PRICE GROWTH RATING
1..100
49
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
BEAMMRUS
RSI
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 2 days ago
72%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
90%
Bullish Trend 2 days ago
89%
Momentum
ODDS (%)
Bullish Trend 1 day ago
79%
Bearish Trend 2 days ago
83%
MACD
ODDS (%)
Bullish Trend 1 day ago
81%
Bearish Trend 2 days ago
75%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
81%
Bearish Trend 2 days ago
80%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
80%
Bearish Trend 2 days ago
78%
Advances
ODDS (%)
Bullish Trend 6 days ago
78%
Bullish Trend 6 days ago
84%
Declines
ODDS (%)
Bearish Trend 16 days ago
85%
Bearish Trend 8 days ago
78%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
90%
N/A
Aroon
ODDS (%)
Bullish Trend 1 day ago
76%
Bullish Trend 2 days ago
82%
View a ticker or compare two or three
Interact to see
Advertisement
BEAM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
MRUS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
FCPIX37.72N/A
N/A
Fidelity Advisor Intl Cap App I
SUHIX42.38N/A
N/A
DWS Health and Wellness Inst
LFEIX23.29N/A
N/A
Federated Hermes Equity Income F
PSGAX28.80N/A
N/A
Virtus KAR Small-Cap Growth A
STPIX28.35N/A
N/A
Saratoga Technology & Comm I

MRUS and

Correlation & Price change

A.I.dvisor indicates that over the last year, MRUS has been loosely correlated with CGON. These tickers have moved in lockstep 49% of the time. This A.I.-generated data suggests there is some statistical probability that if MRUS jumps, then CGON could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MRUS
1D Price
Change %
MRUS100%
-2.30%
CGON - MRUS
49%
Loosely correlated
-2.42%
VIGL - MRUS
49%
Loosely correlated
N/A
IDYA - MRUS
49%
Loosely correlated
-4.25%
RVMD - MRUS
48%
Loosely correlated
-3.17%
ACLX - MRUS
47%
Loosely correlated
-2.40%
More